| 2024年中报 | 2024年一季报 | 2023年年报 | 2022年年报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 防疫类(元) | 668,428,842.96 | 329,000,000.00 | 1,324,616,853.05 | 1,242,378,343.89 |
| 抗感染(元) | 2,722,838,219.05 | 1,371,000,000.00 | 4,946,048,066.41 | 5,089,817,356.66 |
| 农药、兽药类(元) | 413,011,448.66 | 201,000,000.00 | 698,041,871.25 | 753,769,509.76 |
| 神经、血液系统用药(元) | 121,774,804.59 | 55,000,000.00 | 179,947,942.69 | 165,270,240.83 |
| 肾病及免疫调节类(元) | 240,541,688.67 | 120,000,000.00 | 436,000,228.23 | 501,374,989.63 |
| 维生素及健康消费品(元) | 147,482,373.42 | 53,000,000.00 | 233,231,396.97 | 258,111,622.16 |
| 心脑血管类(元) | 153,176,327.98 | 67,000,000.00 | 235,656,642.02 | 191,565,090.38 |
| 医药中间体(元) | 217,596,742.82 | 100,000,000.00 | 718,833,743.43 | 600,781,916.91 |
| 医药及其他物流贸易(元) | 292,246,548.97 | 127,000,000.00 | 771,896,700.11 | 828,294,580.05 |
| 其他(元) | 226,883,242.41 | 122,000,000.00 | 525,606,362.75 | 817,390,845.48 |
| 营业成本(元) | ||||
| 防疫类(元) | 92,151,636.09 | 39,000,000.00 | 187,709,158.61 | 166,291,541.44 |
| 抗感染(元) | 2,172,319,854.82 | 1,090,000,000.00 | 3,851,576,399.46 | 3,562,041,694.81 |
| 农药、兽药类(元) | 354,391,828.92 | 169,000,000.00 | 571,633,780.92 | 614,578,750.99 |
| 神经、血液系统用药(元) | 57,557,371.81 | 28,000,000.00 | 75,843,155.16 | 78,929,851.17 |
| 肾病及免疫调节类(元) | 65,809,001.40 | 36,000,000.00 | 145,438,981.58 | 149,185,443.94 |
| 维生素及健康消费品(元) | 126,851,375.12 | 38,000,000.00 | 182,669,075.18 | 230,496,407.00 |
| 心脑血管类(元) | 83,774,965.82 | 46,000,000.00 | 100,930,025.14 | 116,574,918.12 |
| 医药中间体(元) | 206,313,450.09 | 85,000,000.00 | 585,555,472.03 | 498,568,148.09 |
| 医药及其他物流贸易(元) | 287,307,210.12 | 124,000,000.00 | 764,944,409.05 | 818,005,739.51 |
| 其他(元) | 200,410,092.91 | 113,000,000.00 | 396,106,782.66 | 735,385,266.15 |
| 毛利(元) | ||||
| 防疫类(元) | 576,277,206.87 | 290,000,000.00 | 1,136,907,694.44 | 1,076,086,802.45 |
| 抗感染(元) | 550,518,364.23 | 281,000,000.00 | 1,094,471,666.95 | 1,527,775,661.85 |
| 农药、兽药类(元) | 58,619,619.74 | 32,000,000.00 | 126,408,090.33 | 139,190,758.77 |
| 神经、血液系统用药(元) | 64,217,432.78 | 27,000,000.00 | 104,104,787.53 | 86,340,389.66 |
| 肾病及免疫调节类(元) | 174,732,687.27 | 84,000,000.00 | 290,561,246.65 | 352,189,545.69 |
| 维生素及健康消费品(元) | 20,630,998.30 | 15,000,000.00 | 50,562,321.79 | 27,615,215.16 |
| 心脑血管类(元) | 69,401,362.16 | 21,000,000.00 | 134,726,616.88 | 74,990,172.26 |
| 医药中间体(元) | 11,283,292.73 | 15,000,000.00 | 133,278,271.40 | 102,213,768.82 |
| 医药及其他物流贸易(元) | 4,939,338.85 | 3,000,000.00 | 6,952,291.06 | 10,288,840.54 |
| 其他(元) | 26,473,149.50 | 9,000,000.00 | 129,499,580.09 | 82,005,579.33 |
| 毛利率(%) | ||||
| 防疫类(%) | 86.21 | 88.15 | 85.83 | 86.62 |
| 抗感染(%) | 20.22 | 20.50 | 22.13 | 30.02 |
| 农药、兽药类(%) | 14.19 | 15.92 | 18.11 | 18.47 |
| 神经、血液系统用药(%) | 52.73 | 49.09 | 57.85 | 52.24 |
| 肾病及免疫调节类(%) | 72.64 | 70.00 | 66.64 | 70.24 |
| 维生素及健康消费品(%) | 13.99 | 28.30 | 21.68 | 10.70 |
| 心脑血管类(%) | 45.31 | 31.34 | 57.17 | 39.15 |
| 医药中间体(%) | 5.19 | 15.00 | 18.54 | 17.01 |
| 医药及其他物流贸易(%) | 1.69 | 2.36 | 0.90 | 1.24 |
| 其他(%) | 11.67 | 7.38 | 24.64 | 10.03 |
| 收入构成(%) | ||||
| 防疫类(%) | 12.84 | 12.93 | 13.15 | 11.89 |
| 抗感染(%) | 52.32 | 53.87 | 49.12 | 48.71 |
| 农药、兽药类(%) | 7.94 | 7.90 | 6.93 | 7.21 |
| 神经、血液系统用药(%) | 2.34 | 2.16 | 1.79 | 1.58 |
| 肾病及免疫调节类(%) | 4.62 | 4.72 | 4.33 | 4.80 |
| 维生素及健康消费品(%) | 2.83 | 2.08 | 2.32 | 2.47 |
| 心脑血管类(%) | 2.94 | 2.63 | 2.34 | 1.83 |
| 医药中间体(%) | 4.18 | 3.93 | 7.14 | 5.75 |
| 医药及其他物流贸易(%) | 5.62 | 4.99 | 7.67 | 7.93 |
| 其他(%) | 4.36 | 4.79 | 5.22 | 7.82 |
| 毛利构成(%) | ||||
| 防疫类(%) | 37.01 | 37.32 | 35.45 | 30.93 |
| 抗感染(%) | 35.36 | 36.16 | 34.12 | 43.92 |
| 农药、兽药类(%) | 3.76 | 4.12 | 3.94 | 4.00 |
| 神经、血液系统用药(%) | 4.12 | 3.47 | 3.25 | 2.48 |
| 肾病及免疫调节类(%) | 11.22 | 10.81 | 9.06 | 10.12 |
| 维生素及健康消费品(%) | 1.32 | 1.93 | 1.58 | 0.79 |
| 心脑血管类(%) | 4.46 | 2.70 | 4.20 | 2.16 |
| 医药中间体(%) | 0.72 | 1.93 | 4.16 | 2.94 |
| 医药及其他物流贸易(%) | 0.32 | 0.39 | 0.22 | 0.30 |
| 其他(%) | 1.70 | 1.16 | 4.04 | 2.36 |